Dudediligence.

Benitec Biopharma Inc

BNTCNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Sep ’24$0.00Dec ’24$0.00Mar ’25$0.00Sep ’25$0.00Dec ’25$0.00Mar ’26
Net income, by quarter
−$5.1MSep ’24−$9.6MDec ’24−$14.5MMar ’25−$8.8MJun ’25−$9.0MSep ’25−$11.8MDec ’25−$11.9MMar ’26−$12.8MJun ’26
Fiscal years, by the month each ended
LineJun 2022Jun 2023Jun 2024Jun 2025Jun 2026
Revenue$73,000$75,000$0.00none on filenone on file
Operating income−$17.9M−$19.1M−$22.5M−$41.8M−$51.2M
Net income−$18.2M−$19.6M−$21.8M−$37.9M−$45.5M
Operating cash flow−$15.9M−$18.0M−$19.4M−$23.6M−$16.5M
Free cash flow−$15.9M−$18.0M−$19.6M−$23.6M−$16.6M
Cash$4.1M$2.5M$50.9M$97.7M$180.0M
Shares outstanding480.7K1.7M10.1M26.3M34.4M